Why is Avinger (AVGR) The Biggest Biotech Stock Gainer?

Among the many medical device company stocks that have recorded gains in recent times, the gains made by the Avinger Inc (NASDAQ: AVGR) stock has been particularly eye-catching.

The company, which is already at a commercial-stage, has seen its stock soar by as much as 800% in a month, and on Tuesday, it rallied by 33%. One of the possible reasons behind the continued rally in the stock in recent days could be linked to an announcement on January 15.

On that day, Avinger announced that its product Tigereye has been launched commercially. The product in question is an image-guided chronic total occlusion (CTO) crossing system and it has brought the stock in sharp focus.

Related:  Inovio Pharmaceuticals (INO) Turns Volatile Amid Uncertainty

Considering the fact that the product has been launched commercially, Tigereye can now be ordered by clients in the United States and Germany. It is a major development for the company and it remains to be seen if the Avinger stock can continue to hold on to its momentum in the coming days.


Uson Abdilazhanov

Editor and Computer Expert A hardcore tech enthusiast and computer expert Uson Abdilazhanov who holds a degree in communications started writing in his personal blogs since 2012. That time he was interested in the technical part of the computer. But now the software aspect plays an important role in his career. Currently, he runs a PC building and repairing shop which helps a lot of designers and gamers who always like to try new things.